<DOC>
	<DOCNO>NCT00824291</DOCNO>
	<brief_summary>This multicenter study assess health well-being subject outpatient major depressive disorder take desvenlafaxine succinate sustain release ( DVS SR ) placebo 12 week .</brief_summary>
	<brief_title>Study Evaluating Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Desvenlafaxine Succinate</mesh_term>
	<criteria>Outpatient men woman , age 18 75 year , fluent write spoken English . Employed 20 hour minimum 1 month prior baseline . Primary diagnosis Major Depressive Disorder symptoms least 30 day prior baseline . Treatment desvenlafaxine succinate sustain release time past and/or venlafaxine ( Effexor Effexor XR ) 1 year prior baseline . Treatmentresistant define follow fail treatment past 3 year : 3 previous adequate trial &gt; =2 class antidepressant medication , electroconvulsive therapy , psychotherapy ( 2 adequate trial ) . Current ( within 12 month prior screen visit ) psychoactive substance abuse dependence ( include alcohol ) , manic episode , posttraumatic stress disorder , obsessivecompulsive disorder , lifetime diagnosis bipolar psychotic disorder . Clinically important abnormality physical examination , electrocardiogram ( ECG ) , laboratory evaluation .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Major Depressive Disorder</keyword>
</DOC>